Full Text
POSA38 Cost-Effectiveness Analysis of for Insulin Degludec (TRESIBA®) vs. Insulin Glargine U300 (TOUJEO®) in Algerian Setting

Abstract

Authors

A Abotaleb M Semrouni R Malek A Tebaibia P Azzoug.S. AEM Haddam N Nouri Z Arbouche

Back to ISPOR Europe 2021 Abstracts: Emerging Frontiers and Opportunities
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×